RISPERIDON- IMPLANTATFORMULIERUNG

Patent europeic · EP2854858 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2854858
Numer da la dumonda
EP13726003
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
31-05-2013
Publitgà
08-04-2015
Concedì
10-12-2025
La protecziun finescha il pli tard
30-05-2033
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
A61K 47/34 (2017.01)
Prioritad
EP 12170362 31.05.2012
Dumonda PCT
PCT/EP2013/061320 31.05.2013
Publicaziun PCT
WO2013/178812 05.12.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2026

    Midada

    Published in Swissreg on 21.10.2026

  2. 10-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.12.2025

Partidas

Possessur

LABORATORIOS FARMACEUTICOS ROVI, S.A.

Laboratorios Farmacéuticos Rovi, S.A.

C/ Julián Camarillo 35, 28037 Madrid, ES

Inventur

GUTIERRO ADURIZ, Ibon

E-28037 Madrid, ES

FRANCO RODRÍGUEZ, Guillermo

E-28037 Madrid, ES

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.